SUNCHEN Cordyceps Tablet
Natural health product licensed in Canada
- Licence holder
- Beijing SUNCHEN Aerospace Agricultural Biological Technology Co., Ltd.
- NPN or DIN-HM
- 80077385
- Status
- Active licence
- Licence date
- 10 May 2017
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cordyceps militaris Source : En entier Extract : Matériel brut sec Extraction ratio : 2:1 Dry plant equivalent : 500 milligramme | 250 milligramme | Not calculated |
| Inuline Source : Cichorium intybus - racine | 100 milligramme | Not calculated |
| Fructooligosaccharides Source : Cichorium intybus - racine | 95 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Comprimé | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of fungal polysaccharides with immunomodulating properties. Provides antioxidants that help protect cell against the oxidative damage caused by free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If you are taking any prescription medication, consult a health care practitioner prior to use. If symptoms worsen or if laxative effect does not occur within seven days, consult a health care practitioner. If you are taking medications which inhibit peristaltic movement, consult a health care practitioner prior to use (e.g. opioids, loperamide). If you have symptoms such as abdominal pain, nausea, vomiting or fever, consult a health care practitioner prior to use. If you are experiencing a sudden change in bowel habits that has persisted for more than 2 weeks, undiagnosed rectal bleeding, or have failed to defecate following the use of a laxative product, consult a health care practitioner prior to use.
- Effets indésirables connus
Hypersensitivity has been known to occur.
Source
Official Health Canada record, licence 80077385
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.